Cybin Ownership

CYBN Stock  USD 8.32  0.14  1.65%   
Cybin holds a total of 23.02 Million outstanding shares. 30% of Cybin Inc outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2019-12-31
Previous Quarter
21 M
Current Value
20.9 M
Avarage Shares Outstanding
138.4 M
Quarterly Volatility
96.4 M
 
Covid
Some institutional investors establish a significant position in stocks such as Cybin in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Cybin, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cybin Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Cybin Stock Ownership Analysis

About 49.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.11. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cybin Inc recorded a loss per share of 4.08. The entity had not issued any dividends in recent years. The firm had 1:38 split on the 19th of September 2024. Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. It has also developed EMBARK, a psychedelic-assisted psychotherapy. Cybin operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 50 people. For more info on Cybin Inc please contact the company at 908 764 8385 or go to https://www.cybin.com.
Besides selling stocks to institutional investors, Cybin also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Cybin's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Cybin's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Cybin Quarterly Liabilities And Stockholders Equity

258.62 Million

Cybin Outstanding Bonds

Cybin issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cybin Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cybin bonds can be classified according to their maturity, which is the date when Cybin Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Cybin Corporate Filings

6K
17th of July 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
14th of July 2025
Other Reports
ViewVerify
1st of July 2025
Other Reports
ViewVerify
21st of May 2025
Other Reports
ViewVerify

Pair Trading with Cybin

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cybin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cybin will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Cybin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cybin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cybin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cybin Inc to buy it.
The correlation of Cybin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cybin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cybin Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cybin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cybin Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cybin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cybin Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cybin Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cybin Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cybin. If investors know Cybin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cybin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.08)
Return On Assets
(0.44)
Return On Equity
(0.57)
The market value of Cybin Inc is measured differently than its book value, which is the value of Cybin that is recorded on the company's balance sheet. Investors also form their own opinion of Cybin's value that differs from its market value or its book value, called intrinsic value, which is Cybin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cybin's market value can be influenced by many factors that don't directly affect Cybin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cybin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cybin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cybin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.